Elranatamab Monotherapy Or In Combination With Daratumumab Vs Daratumumab + Pomalidomide + Dexamethasone For Patients With Relapsed/Refractory Multiple Myeloma: Phase 3 Magnetismm-5 Study, Part 2
Elranatamab;Daratumumab;Daratumumab;Dexamethasone;Pomalidomide
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Elranatamab Monotherapy Or In Combination With Daratumumab Vs Daratumumab + Pomalidomide + Dexamethasone For Patients With Relapsed/Refractory Multiple Myeloma: Phase 3 Magnetismm-5 Study, Part 2 ### Output: Elranatamab;Daratumumab;Daratumumab;Dexamethasone;Pomalidomide